Overview
Status
Active
Registry date
2024-02-12
Share capital
5 000,00 PLN
Registered address
ul. Duńska 9/D173, 54-427 Wrocław, Poland
Electronic delivery address
AE:PL-81715-28589-ATCRU-22
Industry
Bank accounts
Registered as a VAT taxpayer on 2024-05-11. Active
20 1140 2004 0000 3402 8467 6280
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 6, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | —— | Wrocławski Park Technologiczny S.A. | |
| Mar 6, 2024 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | —— | Wrocławski Park Technologiczny S.A. |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Marcin Holuk — Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marcin Holuk (45) | 24 | $324.15 | 24% |
Jakub Maciej Kozera (29) | 76 | $1,026.47 | 76% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Marcin Holuk (45) | Shareholder of a limited liability company, 1200.0 PLN | |
Jakub Maciej Kozera (29) | Shareholder of a limited liability company, 3800.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| VASA Therapeuticssp. z o.o. | $216,535.01 | vasatherapeutics.com | ||
| Bactremsp. z o.o. | $181,958.36 | bactrem.pl | ||
| Biodecsp. z o.o. | $115,508.63 | biodec.pl | ||
| AI Corelabsp. z o.o. | $106,857.00 | aicorelab.com | ||
| Pominnosp. z o.o. | $65,991.17 | pominno.pl | ||
| GenomtecS.A. | $47,965.85 | genomtec.com | ||
| ArthecS.A. | $10,911.16 | arthec.eu | ||
| 4cell TherapiesS.A. | $9,123.06 | 4celltherapies.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-06-02 | Address change (Ul. Duńska 9/D166-D166a, 54-427, Wrocław → Ul. Duńska 9/D173, 54-427, Wrocław) | |
| 2024-12-11 | PKD change (Removed: 10.8, 72.1, 74.9; Added: 10.89.Z, 20.13.Z, 20.14.Z, 20.59.Z, 46.75.Z, 47.29.Z, 47.73.Z, 72.19.Z, 74.90.Z) | |
| 2024-05-21 | Address change (Pl. Jana Pawła Ii 33/3, 50-136, Wrocław → Ul. Duńska 9/D166-D166a, 54-427, Wrocław) | |
| 2024-02-12 | Entered in the register |
FAQ
The main business activity of Corepharma Tech focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on February 12, 2024.
The headquarters is located at: ul. Duńska 9, 54-427 Wrocław.
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-10-03